MXPA05011768A - Un metodo para alterar farmacocineticos de insulina. - Google Patents

Un metodo para alterar farmacocineticos de insulina.

Info

Publication number
MXPA05011768A
MXPA05011768A MXPA05011768A MXPA05011768A MXPA05011768A MX PA05011768 A MXPA05011768 A MX PA05011768A MX PA05011768 A MXPA05011768 A MX PA05011768A MX PA05011768 A MXPA05011768 A MX PA05011768A MX PA05011768 A MXPA05011768 A MX PA05011768A
Authority
MX
Mexico
Prior art keywords
methods
insulin delivery
prevention
treatment
present
Prior art date
Application number
MXPA05011768A
Other languages
English (en)
Inventor
Barry Ginsberg
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/429,973 external-priority patent/US7722595B2/en
Priority claimed from US10/704,035 external-priority patent/US20050010193A1/en
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of MXPA05011768A publication Critical patent/MXPA05011768A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3286—Needle tip design, e.g. for improved penetration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona con metodos para la administracion de insulina en el compartimiento intradermico de la piel del sujeto, de preferencia a la vasculatura dermica del compartimiento intradermico. Los metodos de la presente invencion mejoran los parametros farmacocineticos y farmacodinamicos de suministro de insulina y resultado efectivo en una eficacia clinica superior en el tratamiento y/o prevencion de diabetes mellitus. Los metodos de la invencion actual proporcionan un control glicemico mejorado de ambos niveles de glucosa sanguinea en ayuno y sin ayuno (es decir despues de comer) y de este modo tienen una eficacia terapeutica mejorada en el tratamiento, prevencion y/o manejo de diabetes con relacion a los metodos tradicionales de suministro de insulina, incluyendo el suministro de insulina subcutaneo.
MXPA05011768A 2003-05-06 2004-05-06 Un metodo para alterar farmacocineticos de insulina. MXPA05011768A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/429,973 US7722595B2 (en) 2002-05-06 2003-05-06 Method and device for controlling drug pharmacokinetics
US50095603P 2003-09-05 2003-09-05
US10/704,035 US20050010193A1 (en) 2002-05-06 2003-11-06 Novel methods for administration of drugs and devices useful thereof
US52383103P 2003-11-19 2003-11-19
PCT/US2004/014033 WO2004101023A2 (en) 2003-05-06 2004-05-06 A method for altering insulin pharmacokinetics

Publications (1)

Publication Number Publication Date
MXPA05011768A true MXPA05011768A (es) 2006-01-26

Family

ID=33459121

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011768A MXPA05011768A (es) 2003-05-06 2004-05-06 Un metodo para alterar farmacocineticos de insulina.

Country Status (8)

Country Link
EP (1) EP1620145A4 (es)
JP (1) JP2007517768A (es)
KR (1) KR20060009303A (es)
AU (1) AU2004238257A1 (es)
BR (1) BRPI0409984A (es)
CA (1) CA2524444A1 (es)
MX (1) MXPA05011768A (es)
WO (1) WO2004101023A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US10105317B2 (en) * 2009-07-07 2018-10-23 Anpac Bio-Medical Science Co., Ltd. Method of drug delivery
JP2017514810A (ja) * 2014-04-25 2017-06-08 サノフイ インスリン、インスリン類似体またはインスリンの誘導体の新規な投与経路

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623457B1 (en) * 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
US20020198509A1 (en) * 1999-10-14 2002-12-26 Mikszta John A. Intradermal delivery of vaccines and gene therapeutic agents via microcannula
US6565532B1 (en) * 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6607513B1 (en) * 2000-06-08 2003-08-19 Becton, Dickinson And Company Device for withdrawing or administering a substance and method of manufacturing a device
JP2004528896A (ja) * 2001-04-13 2004-09-24 ベクトン・ディキンソン・アンド・カンパニー 皮内に物質を注射する方法
US7556615B2 (en) * 2001-09-12 2009-07-07 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same

Also Published As

Publication number Publication date
CA2524444A1 (en) 2004-11-25
WO2004101023A3 (en) 2007-03-01
KR20060009303A (ko) 2006-01-31
EP1620145A4 (en) 2010-08-25
BRPI0409984A (pt) 2006-05-09
WO2004101023A2 (en) 2004-11-25
AU2004238257A1 (en) 2004-11-25
JP2007517768A (ja) 2007-07-05
EP1620145A2 (en) 2006-02-01

Similar Documents

Publication Publication Date Title
TNSN00206A1 (en) Method for treating diabetes
WO2002065985A3 (en) Methods of treating diabetes mellitus
CA2191714A1 (en) Therapeutic food composition and method to diminish blood sugar fluctuations
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
WO2001032157A3 (en) Pharmaceutical composition comprising a combination of metformin and glibenclamide
MXPA05006634A (es) Fluidos de dialisis biocompatibles que contienen icodextrinas.
WO2003015843A3 (en) Administration of insulin by jet injection
EP2518655A3 (en) Device and method for preventing hypoglycemia
JP2003521528A5 (es)
WO2004003164A3 (en) Methods of organ regeneration
CA2208047A1 (en) Increasing creatine and glycogen concentration in muscle
Schultz et al. Tight glycaemic control: a survey of intensive care practice in the Netherlands
MXPA05011768A (es) Un metodo para alterar farmacocineticos de insulina.
Wang " Pseudoinfarction" Pattern Due to Hyperkalemia
WO2004098676A3 (en) Novel methods for administration of drugs and devices useful thereof
Chlup et al. Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump
WO2004060316A3 (en) Irs modulators
AU2003221468A1 (en) Needle insertion sensor
Patrick et al. The importance of the time interval between insulin injection and breakfast in determining postprandial glycaemic control—a comparison between human and porcine insulin
KR100723806B1 (ko) 인슐린 펌프의 인슐린 주입 제어방법
Castaneda et al. Glycemic Control in Older Adults With Type 2 Dieubefes
Lepore et al. Age and A1C are important clinical predictors of continuous subcutaneous insulin infusion efficacy in type 1 diabetic patients
WO2003082283A3 (en) Pharmaceutical composition with combined active agents and methods for using the same
Szekeres et al. Comparison of the biologic activity of porcine and semisynthetic human insulins using the glucose-controlled insulin infusion system in insulin-dependent diabetes
Sadovsky Inhaled insulin treatment in patients with type 2 diabetes